<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang Z</submitter><funding>Medical Key Professionals Program of Jiangsu Province</funding><funding>Ministry of Science and Technology China 973 Project</funding><funding>National Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>NCI NIH HHS</funding><funding>NIH</funding><pagination>1792-802</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4323690</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(8)</volume><pubmed_abstract>Originally discovered in neuronal guidance, the Slit-Robo pathway is emerging as an important player in human cancers. However, its involvement and mechanism in colorectal cancer (CRC) remains to be elucidated. Here, we report that Slit2 expression is reduced in CRC tissues compared with adjacent noncancerous tissues. Extensive promoter hypermethylation of the Slit2 gene has been observed in CRC cells, which provides a mechanistic explanation for the Slit2 downregulation in CRC. Functional studies showed that Slit2 inhibits CRC cell migration in a Robo-dependent manner. Robo-interacting ubiquitin-specific protease 33 (USP33) is required for the inhibitory function of Slit2 on CRC cell migration by deubiquitinating and stabilizing Robo1. USP33 expression is downregulated in CRC samples, and</pubmed_abstract><journal>International journal of cancer</journal><pubmed_title>USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.</pubmed_title><pmcid>PMC4323690</pmcid><funding_grant_id>20110490615</funding_grant_id><funding_grant_id>81000867</funding_grant_id><funding_grant_id>2010CB529603</funding_grant_id><funding_grant_id>2013CB917803</funding_grant_id><funding_grant_id>91132710</funding_grant_id><funding_grant_id>81071791</funding_grant_id><funding_grant_id>P30 CA060553</funding_grant_id><funding_grant_id>2009CB825402</funding_grant_id><funding_grant_id>81272299</funding_grant_id><funding_grant_id>RC2011031</funding_grant_id><funding_grant_id>R01 CA175360</funding_grant_id><funding_grant_id>R01CA175360</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Quan C</pubmed_authors><pubmed_authors>Kong R</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Wen P</pubmed_authors><pubmed_authors>Du X</pubmed_authors><pubmed_authors>Wu JY</pubmed_authors><pubmed_authors>Fushimi K</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Hua D</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Bian Z</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Cheng H</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors></additional><is_claimable>false</is_claimable><name>USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.</name><description>Originally discovered in neuronal guidance, the Slit-Robo pathway is emerging as an important player in human cancers. However, its involvement and mechanism in colorectal cancer (CRC) remains to be elucidated. Here, we report that Slit2 expression is reduced in CRC tissues compared with adjacent noncancerous tissues. Extensive promoter hypermethylation of the Slit2 gene has been observed in CRC cells, which provides a mechanistic explanation for the Slit2 downregulation in CRC. Functional studies showed that Slit2 inhibits CRC cell migration in a Robo-dependent manner. Robo-interacting ubiquitin-specific protease 33 (USP33) is required for the inhibitory function of Slit2 on CRC cell migration by deubiquitinating and stabilizing Robo1. USP33 expression is downregulated in CRC samples, and</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-06-25T03:04:03.566Z</modification><creation>2025-06-25T03:04:03.566Z</creation></dates><accession>S-EPMC4323690</accession><cross_references><pubmed>25242263</pubmed><doi>10.1002/ijc.29226</doi></cross_references></HashMap>